 Neuroophthalmologic effects intravenous magnesium sulfate hypothesis visual disturbances common intravenous magnesium sulfate administration days discontinuation drug women underwent neuroophthalmologic examinations intravenous magnesium sulfate tocolysis gm hr days cessation therapy Visual symptoms common intravenous magnesium sulfate administration Blurred vision present patients diplopia present patients Abnormal findings neuroophthalmologic examination patients intravenous magnesium sulfate administration Findings ptosis accommodative convergence insufficiency abnormal pupillary responsiveness light patients symptom-free normal examinations magnesium sulfate findings visual disturbances therapeutic magnesium sulfate common